To further investigate the consequences of PHD inhibition, we tested a range of human AML cell lines with diverse mutational backgrounds (detailed in Fig. 5 legend) and found, in accord with our results in murine AML cells, that Dap or IOX5 treatment consistently compromised their proliferation and survival (Fig. 5g,h). The gene discussed is DAP; the disease is acute myeloid leukemia.